COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 115 filers reported holding COGENT BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 1.86 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,123,520 | -90.3% | 316,000 | -91.5% | 0.08% | -92.0% |
| Q4 2023 | $21,817,969 | -26.7% | 3,710,539 | +21.5% | 0.99% | -38.7% |
| Q3 2023 | $29,769,675 | +13.3% | 3,053,300 | +37.6% | 1.61% | +14.5% |
| Q2 2023 | $26,281,165 | +33.9% | 2,219,693 | +22.0% | 1.40% | +69.5% |
| Q1 2023 | $19,634,487 | -6.2% | 1,819,693 | +0.5% | 0.83% | -5.7% |
| Q4 2022 | $20,939,738 | -24.7% | 1,811,396 | -2.7% | 0.88% | -23.8% |
| Q3 2022 | $27,790,000 | +413.5% | 1,862,600 | +210.4% | 1.15% | +460.2% |
| Q2 2022 | $5,412,000 | – | 600,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,884,977 | $52,708,902 | 10.29% |
| COMMODORE CAPITAL LP | 4,772,421 | $51,494,423 | 7.84% |
| TCG Crossover Management, LLC | 3,631,042 | $39,178,943 | 7.64% |
| Fairmount Funds Management LLC | 2,758,975 | $29,769,340 | 5.12% |
| New Leaf Venture Partners, L.L.C. | 501,530 | $5,411,509 | 4.47% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 579,264 | $6,250,259 | 2.58% |
| 5AM Venture Management, LLC | 790,440 | $8,528,848 | 2.18% |
| Ghost Tree Capital, LLC | 550,000 | $5,935,000 | 1.75% |
| Frazier Life Sciences Management, L.P. | 2,159,154 | $23,297,272 | 1.69% |
| HighVista Strategies LLC | 183,984 | $1,985,187 | 1.62% |